View Future GrowthTalea Group 過去の業績過去 基準チェック /06Talea Groupの収益は年間平均-63%の割合で減少していますが、 Consumer Retailing業界の収益は年間 増加しています。収益は年間7.3% 22.9%割合で 増加しています。主要情報-62.97%収益成長率-59.67%EPS成長率Consumer Retailing 業界の成長10.52%収益成長率22.95%株主資本利益率-9.36%ネット・マージン-2.46%前回の決算情報31 Dec 2024最近の業績更新Reported Earnings • Apr 19Full year 2022 earnings released: €0.14 loss per share (vs €0.013 loss in FY 2021)Full year 2022 results: €0.14 loss per share (further deteriorated from €0.013 loss in FY 2021). Revenue: €116.3m (up 41% from FY 2021). Net loss: €948.9k (loss widened €859.2k from FY 2021). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Consumer Retailing industry in Europe.Reported Earnings • Sep 29First half 2022 earnings released: EPS: €0 (vs €0.023 loss in 1H 2021)First half 2022 results: EPS: €0 (improved from €0.023 loss in 1H 2021). Revenue: €52.8m (up 32% from 1H 2021). Net income: €403.8k (up €533.7k from 1H 2021). Profit margin: 0.8% (up from net loss in 1H 2021). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Consumer Retailing industry in Europe.お知らせ • Aug 28Farmaè S.p.A. to Report First Half, 2022 Results on Sep 26, 2022Farmaè S.p.A. announced that they will report first half, 2022 results on Sep 26, 2022Reported Earnings • Apr 19Full year 2021 earnings released: €0.013 loss per share (vs €0.17 loss in FY 2020)Full year 2021 results: €0.013 loss per share (up from €0.17 loss in FY 2020). Revenue: €82.5m (up 29% from FY 2020). Net loss: €89.7k (loss narrowed 91% from FY 2020).すべての更新を表示Recent updatesNew Risk • Apr 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-€14m). Share price has been volatile over the past 3 months (7.1% average weekly change). Market cap is less than US$100m (€36.2m market cap, or US$38.8m).お知らせ • Mar 29+ 2 more updatesTalea Group S.p.A., Annual General Meeting, Apr 29, 2024Talea Group S.p.A., Annual General Meeting, Apr 29, 2024.New Risk • Mar 11New major risk - Revenue and earnings growthEarnings have declined by 61% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 61% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-€11m). Market cap is less than US$100m (€46.4m market cap, or US$50.7m).Buying Opportunity • May 24Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be €13.88, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 33% over the last 3 years. Earnings per share has grown by 5.5%. Revenue is forecast to grow by 27% in a year. Earnings is forecast to grow by 89% in the next year.Reported Earnings • Apr 19Full year 2022 earnings released: €0.14 loss per share (vs €0.013 loss in FY 2021)Full year 2022 results: €0.14 loss per share (further deteriorated from €0.013 loss in FY 2021). Revenue: €116.3m (up 41% from FY 2021). Net loss: €948.9k (loss widened €859.2k from FY 2021). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Consumer Retailing industry in Europe.Board Change • Feb 23Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Marco Guidi was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jan 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Marco Guidi was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Nov 23Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Marco Guidi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Buying Opportunity • Oct 01Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 29%. The fair value is estimated to be €12.08, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 58% in 2 years. Earnings is forecast to grow by 2,339% in the next 2 years.Reported Earnings • Sep 29First half 2022 earnings released: EPS: €0 (vs €0.023 loss in 1H 2021)First half 2022 results: EPS: €0 (improved from €0.023 loss in 1H 2021). Revenue: €52.8m (up 32% from 1H 2021). Net income: €403.8k (up €533.7k from 1H 2021). Profit margin: 0.8% (up from net loss in 1H 2021). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Consumer Retailing industry in Europe.お知らせ • Aug 28Farmaè S.p.A. to Report First Half, 2022 Results on Sep 26, 2022Farmaè S.p.A. announced that they will report first half, 2022 results on Sep 26, 2022Buying Opportunity • Aug 17Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 4.9%. The fair value is estimated to be €15.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 39% over the last 3 years. Meanwhile, the company became loss making.Board Change • Jul 06Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Marco Guidi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Director Marco Guidi was the last director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 19Full year 2021 earnings released: €0.013 loss per share (vs €0.17 loss in FY 2020)Full year 2021 results: €0.013 loss per share (up from €0.17 loss in FY 2020). Revenue: €82.5m (up 29% from FY 2020). Net loss: €89.7k (loss narrowed 91% from FY 2020).Board Change • Mar 19Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Director Marco Guidi was the last director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.収支内訳Talea Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:U5Y 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 24132-38030 Sep 24139-610030 Jun 24138-847031 Mar 24135-846031 Dec 23139-89030 Sep 23138-526030 Jun 23136-244031 Mar 23126-241031 Dec 22116-138030 Sep 22106035030 Jun 2296032031 Mar 2289030031 Dec 2182027030 Sep 2177029030 Jun 2172031031 Mar 2168-126031 Dec 2064-121030 Sep 205804030 Jun 205104031 Mar 204503031 Dec 193802030 Sep 193402030 Jun 193101031 Mar 192801031 Dec 182501031 Dec 1713010質の高い収益: U5Yは現在利益が出ていません。利益率の向上: U5Yは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: U5Yは利益が出ておらず、過去 5 年間で損失は年間63%の割合で増加しています。成長の加速: U5Yの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: U5Yは利益が出ていないため、過去 1 年間の収益成長をConsumer Retailing業界 ( 2.8% ) と比較することは困難です。株主資本利益率高いROE: U5Yは現在利益が出ていないため、自己資本利益率 ( -9.36% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YConsumer-retailing 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/11/02 19:14終値2025/08/05 00:00収益2024/12/31年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Talea Group S.p.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Mattia PetraccaIntegrae SPADaniele AlibrandiStifel, Equities Research
Reported Earnings • Apr 19Full year 2022 earnings released: €0.14 loss per share (vs €0.013 loss in FY 2021)Full year 2022 results: €0.14 loss per share (further deteriorated from €0.013 loss in FY 2021). Revenue: €116.3m (up 41% from FY 2021). Net loss: €948.9k (loss widened €859.2k from FY 2021). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Consumer Retailing industry in Europe.
Reported Earnings • Sep 29First half 2022 earnings released: EPS: €0 (vs €0.023 loss in 1H 2021)First half 2022 results: EPS: €0 (improved from €0.023 loss in 1H 2021). Revenue: €52.8m (up 32% from 1H 2021). Net income: €403.8k (up €533.7k from 1H 2021). Profit margin: 0.8% (up from net loss in 1H 2021). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Consumer Retailing industry in Europe.
お知らせ • Aug 28Farmaè S.p.A. to Report First Half, 2022 Results on Sep 26, 2022Farmaè S.p.A. announced that they will report first half, 2022 results on Sep 26, 2022
Reported Earnings • Apr 19Full year 2021 earnings released: €0.013 loss per share (vs €0.17 loss in FY 2020)Full year 2021 results: €0.013 loss per share (up from €0.17 loss in FY 2020). Revenue: €82.5m (up 29% from FY 2020). Net loss: €89.7k (loss narrowed 91% from FY 2020).
New Risk • Apr 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-€14m). Share price has been volatile over the past 3 months (7.1% average weekly change). Market cap is less than US$100m (€36.2m market cap, or US$38.8m).
お知らせ • Mar 29+ 2 more updatesTalea Group S.p.A., Annual General Meeting, Apr 29, 2024Talea Group S.p.A., Annual General Meeting, Apr 29, 2024.
New Risk • Mar 11New major risk - Revenue and earnings growthEarnings have declined by 61% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 61% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-€11m). Market cap is less than US$100m (€46.4m market cap, or US$50.7m).
Buying Opportunity • May 24Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be €13.88, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 33% over the last 3 years. Earnings per share has grown by 5.5%. Revenue is forecast to grow by 27% in a year. Earnings is forecast to grow by 89% in the next year.
Reported Earnings • Apr 19Full year 2022 earnings released: €0.14 loss per share (vs €0.013 loss in FY 2021)Full year 2022 results: €0.14 loss per share (further deteriorated from €0.013 loss in FY 2021). Revenue: €116.3m (up 41% from FY 2021). Net loss: €948.9k (loss widened €859.2k from FY 2021). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Consumer Retailing industry in Europe.
Board Change • Feb 23Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Marco Guidi was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jan 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Marco Guidi was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Nov 23Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Marco Guidi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Buying Opportunity • Oct 01Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 29%. The fair value is estimated to be €12.08, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 58% in 2 years. Earnings is forecast to grow by 2,339% in the next 2 years.
Reported Earnings • Sep 29First half 2022 earnings released: EPS: €0 (vs €0.023 loss in 1H 2021)First half 2022 results: EPS: €0 (improved from €0.023 loss in 1H 2021). Revenue: €52.8m (up 32% from 1H 2021). Net income: €403.8k (up €533.7k from 1H 2021). Profit margin: 0.8% (up from net loss in 1H 2021). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Consumer Retailing industry in Europe.
お知らせ • Aug 28Farmaè S.p.A. to Report First Half, 2022 Results on Sep 26, 2022Farmaè S.p.A. announced that they will report first half, 2022 results on Sep 26, 2022
Buying Opportunity • Aug 17Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 4.9%. The fair value is estimated to be €15.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 39% over the last 3 years. Meanwhile, the company became loss making.
Board Change • Jul 06Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Marco Guidi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Director Marco Guidi was the last director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 19Full year 2021 earnings released: €0.013 loss per share (vs €0.17 loss in FY 2020)Full year 2021 results: €0.013 loss per share (up from €0.17 loss in FY 2020). Revenue: €82.5m (up 29% from FY 2020). Net loss: €89.7k (loss narrowed 91% from FY 2020).
Board Change • Mar 19Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Director Marco Guidi was the last director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.